Publications (536) JUAN TAMARGO MENÉNDEZ publications

filter_list

2025

  1. 2024 EACTS Guidelines on perioperative medication in adult cardiac surgery

    European Journal of Cardio-thoracic Surgery, Vol. 67, Núm. 1

  2. Antiarrhythmic drugs

    Springer Nature, pp. 1-526

  3. Class III antiarrhythmic drugs

    Antiarrhythmic Drugs (Springer Nature), pp. 133-172

  4. Drug interactions of antiarrhythmic drugs

    Antiarrhythmic Drugs (Springer Nature), pp. 311-342

  5. Introduction to the second edition

    Antiarrhythmic Drugs (Springer Nature), pp. ix-x

  6. Linee guida ESC 2024 per la gestione della fibrillazione atriale

    Giornale italiano di cardiologia (2006), Vol. 26, Núm. 2, pp. 1e-104e

  7. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2024

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 11, Núm. 3, pp. 292-317

  8. Two concurrent mechanisms are responsible for the INa increase produced by dapagliflozin and empagliflozin in healthy and heart failure cardiomyocytes

    Biomedicine and Pharmacotherapy, Vol. 186

2024

  1. 2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

    European Heart Journal, Vol. 45, Núm. 36, pp. 3314-3414

  2. After 30 years, the first endothelin-receptor antagonist (Aprocitentan) is approved for the treatment of arterial hypertension

    European heart journal. Cardiovascular pharmacotherapy, Vol. 10, Núm. 5, pp. 371-373

  3. An account on the history of pharmacology in Spain

    Pharmacological Research

  4. Are NOACs always the best strategy in elderly AF patients?

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 10, Núm. 2, pp. 100-102

  5. Cardiovascular Therapy in Women with Hypertension or Heart Failure

    Manual of Cardiovascular Disease in Women (Springer Nature), pp. 419-443

  6. Coexistent HCN4 and GATA5 Rare Variants and Atrial Fibrillation in a Large Spanish Family

    Canadian Journal of Cardiology, Vol. 40, Núm. 7, pp. 1270-1280

  7. Corrigendum to: An account on the history of pharmacology in Spain [Pharmacol. Res. 202 (2024) 107104 Pages 1–11 https://doi.org/10.1016/j.phrs.2024.107104] (Pharmacological Research (2024) 202, (S1043661824000483), (10.1016/j.phrs.2024.107104))

    Pharmacological Research

  8. Drug-induced atrial fibrillation. A narrative review of a forgotten adverse effect

    Pharmacological Research, Vol. 200

  9. Investigative agents for atrial fibrillation: agonists and stimulants, progress and expectations

    Expert Opinion on Investigational Drugs, Vol. 33, Núm. 9, pp. 967-978

  10. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023

    European Heart Journal - Cardiovascular Pharmacotherapy, Vol. 10, Núm. 3, pp. 219-244

  11. News in cardiovascular pharmacotherapy from the ACC.24 Meeting

    European heart journal. Cardiovascular pharmacotherapy

  12. Reply to Benndorff and DiFrancesco: Reliable human HCN4 single-channel recordings using the cell-attached configuration in expression systems

    Proceedings of the National Academy of Sciences of the United States of America